Yes, I think BP, especially within the HIV circle would be more efficient. I was assuming going alone. My guess, which I’m not counting here, also some R5 patients that had maraviroc but developed resistance and possibly other maraviroc patients on standard haart could switch for less side effects. Also, the R5 strain I was estimating lower in sicker patients, 50%, just being conservative for a lower end estimate. Not what I feel they could do.